News Partner Content Is pharma marketing built on straw, sticks, or bricks? 6th December | 1pm | Royal Society of Medicine
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
